A Case of Disseminated Cutaneous<i>Mycobacterium chelonae</i>Infection During Treatment With Tofacitinib
Vinit Gilvaz, Elinor Mody, Saud Abaalkhail
The Journal of Rheumatology · 2021-07
Abstract
Janus kinase ( JAK) inhibitors, like other immunomodulators, are known to be associated with an increased risk of infections. 1 An analysis of long-term clinical trial data has shown tuberculosis to be the most common opportunistic infection associated with tofacitinib use. 2
MeSH terms
- Tofacitinib
- Medicine
- Mycobacterium chelonae
- Dermatology
- Mycobacterium Infections
- Virology
- Mycobacterium
- Immunology